Skip to main content
We use cookies to improve our service and to tailor our content and advertising to you.
More info
You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our
cookies policy
.
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are here
Home
adult-onset Still’s disease
Email alerts
adult-onset Still’s disease
Some concerns from Turkey
Emre
Bilgin
,
İrem
Ozarli
,
Levent
Kılıç
,
Ertuğrul Çağrı
Bölek
,
Gözde Kübra
Yardımcı
,
Ömer
Karadağ
Annals of the Rheumatic Diseases
Nov 2018,
annrheumdis-2018-214739;
DOI:
10.1136/annrheumdis-2018-214739
Tocilizumab in patients with adult-onset still’s disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial
Yuko
Kaneko
,
Hideto
Kameda
,
Kei
Ikeda
,
Tomonoti
Ishii
,
Kosaku
Murakami
,
Hyota
Takamatsu
,
Yoshiya
Tanaka
,
Takayuki
Abe
,
Tsutomu
Takeuchi
Annals of the Rheumatic Diseases
Dec 2018,
77
(12)
1720-1729;
DOI:
10.1136/annrheumdis-2018-213920
Response to: ‘Is the PET/CT first choice for differential diagnosis of FUO/IUO?’ by Armagan
et al
Verena
Schönau
,
Georg
Schett
Annals of the Rheumatic Diseases
Nov 2018,
77
(11)
e83;
DOI:
10.1136/annrheumdis-2017-212785
CLINICAL
Diagnostics
Clinical diagnostic tests
(1563)
Radiology (diagnostics)
(921)
Surgical diagnostic tests
(505)
Drugs and medicines
Endocrinology
Calcium and bone
(938)
Evidence based practice
Guidelines
(35)
Gastroenterology
Inflammatory bowel disease
(98)
Genetics
(1272)
Immunology (including allergy)
(6648)
Infectious diseases
Bone and joint infections
(93)
Travel medicine
(42)
Neurology
Muscle disease
(198)
Pain (neurology)
(1113)
Nutrition and metabolism
Obesity (nutrition)
(142)
Obstetrics and gynaecology
Menopause (including HRT)
(60)
Ophthalmology
(155)
Orthopaedics
Pathology
Inflammation
(1572)
Pathology
(531)
Pharmacology and therapeutics
Unwanted effects / adverse reactions
(15)
Pharmacology and therapeutics
Radiology
(1357)
Rehabilitation medicine
Disability
(32)
Other rehabilitative therapies
(18)
Physiotherapy
(52)
Renal medicine
(247)
Respiratory medicine
Interstitial lung disease
(181)
Pulmonary hypertension
(39)
Rheumatology
Ankylosing spondylitis
(567)
Biological agents
(731)
Connective tissue disease
(5506)
Degenerative joint disease
(6038)
Drugs: musculoskeletal and joint diseases
(916)
Fibromyalgia
(51)
Musculoskeletal syndromes
(6412)
Osteoarthritis
(1189)
Osteoporosis
(160)
Rheumatoid arthritis
(4213)
Sjogren's syndrome
(6)
Systemic lupus erythematosus
(724)
Vascularitis
(367)
Sports and exercise medicine
Physiotherapy
(33)
NON-CLINICAL
Epidemiology
(1862)
Health economics
(51)
Medical education
Postgraduate
(5)
Occupational and environmental medicine
(32)
Statistics and research methods
Special collections
ARD Lay summaries
(83)
Editor's choice
(161)
Guidelines, Recommendations and Consensus Statements
Open access
(1199)
Press releases
(50)
